Bryan Betty: Wegovy, weightloss drugs, and obesity - Saturday Morning with Jack Tame

A new weightloss medication is now available in New Zealand – accessible on a private, nonsubsidised script. 

Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. 

What is Wegovy?  

• A once-weekly injection for weight loss known as a ‘GP-1 agonist’.  
• It mimics a hormone in the gut that reduces our desire to eat and controls sugar in the blood.  
• Developed originally for diabetes but found to help with weight loss, especially at higher doses.  
• The same drug at lower does is known as Ozempic, which is used for diabetes.  

Is obesity a problem in New Zealand? Why medication? Shouldn’t we just eat better and move more?  

• We do have problem in New Zealand with obesity – it's a major heath issue.  
• Over a third population is classified as obese, and it costs the economy $2 billion a year in healthcare costs. 
• A good diet and exercise are critically important for weight loss.  
• However once above BMI 30, it can be very hard to lose weight despite a person’s lifestyle, so medication can be a useful adjunct for some people in weight loss.

How do we use it and are there side-effects?  

• Once-weekly injection. You adjust the dose every month until you reach the maximum dose.  
• Side effects can include nausea, bloating, loose bowel motions, burping.  
• More serious ones can occur but are very rare: pancreas inflammation, bowel obstruction.  
• Most people have few issues.  

Is there a cost and how long do you take it for?  

• It is not funded by Pharmac and costs about $500 a month or $6000 a year.  
• Many studies now show that when you stop, the weight can go back on.  
• There is a shift to thinking these medications may need to be used long-term, much like a blood pressure or diabetes medication.  
• It is safe for long term use. 

LISTEN ABOVE 

See omnystudio.com/listener for privacy information.